Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection

Documenti analoghi

• Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss
  di: Fei Gu, et al.
  Pubblicazione: (2024)
• What is the real sword of HBV precore and basal core promoter mutations piercing the hepatocyte homeostasis: HBcAg or HBsAg?
  di: Guixin Li, et al.
  Pubblicazione: (2024)
• Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients
  di: Takanori Suzuki, et al.
  Pubblicazione: (2024)
• HBcrAg Dynamic Change During Treatment Predicts HBsAg Loss in Pediatric Patients With Chronic Hepatitis B
  di: Ling Ye, et al.
  Pubblicazione: (2025)
• Hepatitis B Viral Rebound in People With HIV Under HBV‐Active Antiretroviral Therapy
  di: Costanza Bertoni, et al.
  Pubblicazione: (2025)